Burnt-Out MASLD Predicts Outcomes After Curative Resection for Hepatocellular Carcinoma [0.03%]
坏死的中性粒细胞胞外陷阱与肝细胞癌患者的预后关系
Yukihiro Watanabe,Masayasu Aikawa,Yoshiki Murase et al.
Yukihiro Watanabe et al.
Background and aims: Hepatic steatosis often diminishes as metabolic dysfunction-associated steatotic liver disease (MASLD) progresses, leading to a so-called 'burnt-out' state. Whether this phenotype simply reflects adva...
A Novel Viscoelastic Tool Highlighting Severity-Dependent Platelet Dysfunction in Cirrhosis [0.03%]
一种新型粘弹性工具揭示肝硬化中血小板功能障碍的严重性依赖性
Vincenzo La Mura,Niccolò Bitto,Armando Tripodi
Vincenzo La Mura
Non-Selective Beta-Blockers and Portal Vein Thrombosis in Cirrhosis: Before We Sound the Alarm [0.03%]
非选择性β阻滞剂与肝硬化门静脉血栓：我们在敲响警钟之前需要注意什么问题
Anderson Brito-Azevedo,Ubiratan Cassano-Santos
Anderson Brito-Azevedo
Reframing Wnt/β-Catenin Signalling in Liver Fibrosis: Transcriptional State Regulation by CBP and p300 [0.03%]
肝纤维化中Wnt/β-连环蛋白信号转导的再评价：CBP和p300介导的转录状态调节作用
Kiminori Kimura,Michinori Kohara
Kiminori Kimura
Liver fibrosis is a shared pathological phenotype of chronic liver diseases of diverse etiologies, including viral hepatitis, alcohol-associated liver disease and metabolic dysfunction-associated steatohepatitis (MASH), as well as cholestat...
Role of Gram-Negative Bacterial Infections in Acute-On-Chronic Liver Failure [0.03%]
革兰氏阴性菌感染在急性-on-慢性肝功能衰竭中的作用
Camilla Cadoli,Volker Müller,Christoph Welsch et al.
Camilla Cadoli et al.
Acute-on-chronic liver failure (ACLF) is a systemic disease characterised by an acute clinical deterioration of pre-existing liver cirrhosis leading to multiple organ failure due to systemic inflammation. It may be triggered by the transloc...
What Can We Learn From Longitudinal Measurements of Liver Stiffness in Metabolic Dysfunction-Associated Steatotic Liver Disease? [0.03%]
代谢功能障碍相关脂肪性肝病纵向肝硬度测量的意义是什么？
Stéphanie André-Dumont,Nicolas Lanthier
Stéphanie André-Dumont
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide and can potentially progress to fibrosis, cirrhosis, hepatocellular carcinoma and liver failure. Vibration-controlled tra...
The Link of Portal-Hypertensive Gastropathy to Anaemia, Systemic Inflammation and Disease Progression in Cirrhosis [0.03%]
肝硬化患者门脉高压性胃病与贫血、全身炎症及疾病进展的相关性研究
Nikolaus Pfisterer,Irina Lie-Ungurean,Jurij Maurer et al.
Nikolaus Pfisterer et al.
Background and aims: Portal-hypertensive gastropathy (PHG) is considered a potential cause of chronic bleeding and anaemia in patients with advanced chronic liver disease (ACLD) and might represent an endoscopic reflectio...
Primary Sclerosing Cholangitis Recurrence After Liver Transplantation: A Systematic Review and Updated Meta-Analysis [0.03%]
原发性硬化性胆管炎肝移植复发：系统评价和更新的 meta 分析
Isabelle Castro Vitor,Milena Ramos Tomé,Wellgner Fernandes Oliveira Amador et al.
Isabelle Castro Vitor et al.
Background and aims: Primary sclerosing cholangitis (PSC) is an immune-mediated cholestatic liver disease. Liver transplantation (LT) remains the only definitive treatment for patients with advanced disease. However, recu...